{"text": "a terminally-ill , father-of-three who spent the last few months begging pharmaceutical companies to give him an unapproved cancer drug has died , it emerged today . nick auden , 41 , from denver , died from stage 4 melanoma at his home on friday surrounded by his wife amy and his children locky , seven , hayley , five , and evan , one . nick and his family believed that the immune-boosting cancer drug anti-pd-1 would be able to shrink his tumors for good . scroll down for video ... loving family : nick auden , 41 , -lrb- right -rrb- with his wife and three children before he was told by doctors he only had six months to live . blowing bubbles : nick auden said he wanted to stay alive to watch his three young children grow up . pd-1 - programmed cell death protein 1 - . is a protein that in humans is encoded by the pdcd1 gene and is . currently in clinical trials for cancer treatment . his family had been campaigning for access to a clinical trial of the drug , a treatment currently being tested by pharmaceutical companies merck and bristol-myers squibb -lrb- bms -rrb- . an online petition called save . locky 's dad garnered half a million signatures . but nick could not . convince either company to give him the drug . last week , he flew to md anderson . cancer center in houston with wife amy for a last-ditch experimental . treatment that they hoped would stop the cancer from spreading , cancer . connect reports . but it was too late . after being . admitted to intensive care during the treatment , he was flown to his . denver home on tuesday in an air ambulance so he could spend his last . days with his family . ` we were airlifted back to denver mid last week . we got home in time so . the kids could see him . it is a tragedy and i am barely coming to terms . with it , ' his wife told cancer connect on sunday . lost his battle : denver man , nick auden , died at his home on friday surrounded by his family . help us : nick auden 's wife , amy , pleaded with people to sign a petition to ask the drug companies to give her husband the wonder drug . ' i need my dad ' : nick auden 's son , locky , 7 , said in the campaign he wanted his dad to stay alive so they can do things together . brain tumour : auden did not qualify for the clinical trial for the cancer drugs because he had a brain tumour , among other complications . the father-of-three did not qualify for a clinical trial because of a health complication . auden said he was told that in order to be accepted into a clinical trial for the anti-pd-1 drug , he would need to have either no brain tumors or brain tumors that were at least no longer growing . dr jedd wolchok , an oncologist , who is a melanoma specialist at memorial sloan-kettering cancer center in new york , says the drug had the potential to cause brain swelling in people with existing brain disease . since auden had brain tumours , he and his doctor worked to stabilise the tumours using a combination of drugs and other therapies . after months of monitoring his brain scans , in july , auden got good news : his tumors had not grown , and he qualified for the merck trial . but hours later , auden experienced abdominal pain and went straight to an emergency room , because there was a possibility he had a perforated intestine . sure enough , he did , and he was instantly disqualified from the trial . without the drug , auden 's doctor told his . wife , amy , that ` this is the end of the road ' , and that her husband had . between six and nine months to live . auden 's story started in march 2010 , when he had a cancerous mole removed . although it put him at risk for more skin cancer , he continued to live an active life , running , biking and hiking . but in september 2011 , auden said his doctors told him the cancer had returned and had spread throughout his body . the official diagnosis was stage 4 melanoma , which around 90 per cent of people do not survive . but when he learned about the anti-pd-1 drugs and their ability to treat melanoma , he saw a chance to survive . wonder drug : studies of merck 's version of the drug found that 38 per cent of participants in a clinical trial for patients with melanoma saw tumours shrink . not approved : pharmaceutical company bristol-myers squibb , based in new york , is one of the two companies still trialing the anti-pd1-1 drugs . studies of merck 's version of the drug found that 38 per cent of participants in a clinical trial for patients with melanoma saw tumors shrink . of those who took the highest doses of the drug , 52 per cent experienced tumor shrinkage . wolchok , who has not met or treated auden but has corresponded with him through email , told abcnews that immune cells typically do n't attack cancer in a meaningful way because of a kind of natural brake function called pd-1 . there are currently no anti-pd-1 drugs in ` compassionate use ' trials -- trials for individuals who do n't qualify for clinical trials but still want the drug , but according to wolchok , if the medication works , ` some people might even be cured ' . auden 's only chance of survival was to become an individual case study under compassionate use rules , which give people access to experimental drugs even if they do n't fit into clinical trials . that 's when the ` save locky 's dad ' campaign took hold .", "summary": " nick auden , 41 , died from stage four melanoma at his home on friday surrounded by his family .   had been campaigning to receive new cancer drug that would shrink tumors .   online petition garnered half a million signatures .   pharmaceutical companies said he did not qualify for ` wonder drug ' "}